February 2023

Restricted diets are commonplace at many cancer centers, but there is no evidence that they reduce a patient’s risk of infection.

Prior authorization costs clinicians time and money. Heading into 2023, prior authorization was listed as a top administrative challenge.

Nursing education should be viewed as a long-course endeavor rather than a sprint.

Triple-negative breast cancer often occurs in women younger than 40.

Oncology nurses provide perspective on the changing standards of care for patients with triple-negative breast cancer.

As the therapy continues to evolve, best nursing practices become more nuanced.

Osheka Hansel, APRN, discusses the recent approval of futibatinib (Lytgobi) for patients with unresectable, locally advanced or metastatic intrahepatic FGFR2-positive cholangiocarcinoma.